Hurley Capital’s Lam Research LRCX Stock Holding History

Hurley Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30	Closed	-$4.02K	–	688
2025 Q3	$4.02K	Buy	+30	New	+$3.18K	﹤0.01%	472

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Hurley Capital's LRCX Position: Q4 2025 in Review

Hurley Capital sold out of Lam Research (LRCX) in Q4 2025, closing a stake of 30 shares — an estimated $4.02K sold.

Hurley Capital first reported a position in LRCX in Q3 2025 and held it in 1 quarter. The position peaked at $4.02K in Q3 2025. 2,388 funds tracked by Wall St. Rank hold LRCX as of Q4 2025.

Hurley Capital reported no remaining Lam Research position as of Q4 2025 after selling out during the quarter.
Hurley Capital sold 30 Lam Research shares in Q4 2025, an estimated $4.02K.
Hurley Capital first reported a position in Lam Research in Q3 2025 and held it in 1 quarter.
Hurley Capital's Lam Research position peaked at $4.02K in Q3 2025.
2,388 funds tracked by Wall St. Rank held Lam Research as of Q4 2025.

Based on Hurley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.